BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25757200)

  • 1. The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG-PET/CT study.
    Liu G; Li Y; Hu P; Cheng D; Shi H
    Nucl Med Commun; 2015 Jul; 36(7):709-16. PubMed ID: 25757200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies].
    Batallés SM; Villavicencio RL; Quaranta A; Burgos L; Trezzo S; Staffieri R; Pezzotto SM
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):26-32. PubMed ID: 23177341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
    Abele JT; Fung CI
    Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.
    Song HJ; Cheng JY; Hu SL; Zhang GY; Fu Y; Zhang YJ
    Clin Radiol; 2015 Feb; 70(2):128-37. PubMed ID: 25459673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging features of colorectal liver metastasis in FDG PET-CT: a retrospective correlative analysis between CT attenuation and FDG uptake.
    Au-Yeung AW; Luk WH; Lo AX
    Nucl Med Commun; 2012 Apr; 33(4):403-7. PubMed ID: 22273638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
    Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging.
    Demeure F; Hanin FX; Bol A; Vincent MF; Pouleur AC; Gerber B; Pasquet A; Jamar F; Vanoverschelde JL; Vancraeynest D
    J Nucl Med; 2014 Oct; 55(10):1629-35. PubMed ID: 25082852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET/CT.
    Dostbil Z; Varoğlu E; Serdengeçti M; Kaya B; Onder H; Sari O
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):156-61. PubMed ID: 23177332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
    Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C
    Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis.
    Tanaka S; Ikeda K; Uchiyama K; Iwamoto T; Sanayama Y; Okubo A; Nakagomi D; Takahashi K; Yokota M; Suto A; Suzuki K; Nakajima H
    Rheumatology (Oxford); 2013 Jul; 52(7):1271-8. PubMed ID: 23479721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal FDG distribution patterns in the head and neck: PET/CT evaluation.
    Nakamoto Y; Tatsumi M; Hammoud D; Cohade C; Osman MM; Wahl RL
    Radiology; 2005 Mar; 234(3):879-85. PubMed ID: 15734938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors.
    Malladi A; Viner M; Jackson T; Mercier G; Subramaniam RM
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):169-75. PubMed ID: 23551774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of varying serum glucose levels on 18F-FDG biodistribution.
    Webb RL; Landau E; Klein D; DiPoce J; Volkin D; Belman J; Voutsinas N; Brenner A
    Nucl Med Commun; 2015 Jul; 36(7):717-21. PubMed ID: 25888357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
    Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
    Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
    J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.